Results     02-May-22
Announcements
Alembic Pharmaceuticals consolidated net profit declines 85.86% in the March 2022 quarter
Sales rise 10.57% to Rs 1415.74 crore
Net profit of Alembic Pharmaceuticals declined 85.86% to Rs 35.46 crore in the quarter ended March 2022 as against Rs 250.70 crore during the previous quarter ended March 2021. Sales rose 10.57% to Rs 1415.74 crore in the quarter ended March 2022 as against Rs 1280.39 crore during the previous quarter ended March 2021.

For the full year,net profit declined 53.68% to Rs 545.68 crore in the year ended March 2022 as against Rs 1178.11 crore during the previous year ended March 2021. Sales declined 1.62% to Rs 5305.79 crore in the year ended March 2022 as against Rs 5393.13 crore during the previous year ended March 2021.

ParticularsQuarter EndedYear Ended
 Mar. 2022Mar. 2021% Var.Mar. 2022Mar. 2021% Var.
Sales1415.741280.39 11 5305.795393.13 -2
OPM %11.3125.01 -16.4827.45 -
PBDT163.67343.08 -52 906.891551.55 -42
PBT40.59291.86 -86 620.111368.08 -55
NP35.46250.70 -86 545.681178.11 -54

Previous News
  Alembic Pharma’s Gujarat facility gets 4 observations from USFDA
 ( Hot Pursuit - 09-Mar-24   09:04 )
  Alembic Pharmaceuticals to table results
 ( Corporate News - 24-Apr-23   17:42 )
  Alembic Pharmaceuticals consolidated net profit rises 596.17% in the March 2023 quarter
 ( Results - Announcements 05-May-23   17:32 )
  Alembic Pharma suspends Sikkim facility operations due to floods
 ( Hot Pursuit - 04-Oct-23   14:39 )
  Alembic's Bioequivalence facility successfully concludes USFDA inspection
 ( Corporate News - 29-Aug-22   13:13 )
  Alembic Pharma Q4 PAT zooms to Rs 153 cr; R&D spend at Rs 136 crore
 ( Hot Pursuit - 06-May-23   14:44 )
  Board of Alembic Pharmaceuticals recommends final dividend
 ( Corporate News - 06-May-23   09:20 )
  Alembic Pharma reports turnaround Q1 numbers
 ( Hot Pursuit - 05-Aug-23   12:56 )
  Alembic Pharmaceuticals receives USFDA tentative approval for Brexpiprazole Tablets
 ( Corporate News - 09-Mar-23   10:39 )
  Alembic Pharmaceuticals receives USFDA approval for Mesalamine ER Capsules
 ( Corporate News - 02-Nov-22   09:40 )
  Alembic Pharma gets tentative USFDA nod for Brexpiprazole tablets
 ( Hot Pursuit - 09-Mar-23   09:18 )
Other Stories
  Kronox Lab Sciences standalone net profit rises 140.98% in the March 2024 quarter
  29-Jun-24   07:31
  Performance Chemiserve standalone net profit rises 6062.22% in the March 2024 quarter
  27-Jun-24   07:24
  Sundew Properties standalone net profit rises 119.15% in the March 2024 quarter
  27-Jun-24   07:24
  IKF Home Finance standalone net profit rises 42.15% in the March 2024 quarter
  27-Jun-24   07:24
  Delhi Transco standalone net profit rises 1.08% in the March 2024 quarter
  27-Jun-24   07:24
  Profectus Capital Pvt standalone net profit rises 12.12% in the March 2024 quarter
  27-Jun-24   07:24
  Shrem Infra Invest Pvt consolidated net profit rises 290.12% in the March 2024 quarter
  27-Jun-24   07:24
  Bharat Ekansh reports consolidated net loss of Rs 0.01 crore in the March 2024 quarter
  27-Jun-24   07:24
  Patel KNR Heavy Infrastructures reports standalone net loss of Rs 2.71 crore in the March 2024 quarter
  27-Jun-24   07:24
  Supreme Infrastructure India reports consolidated net loss of Rs 326.26 crore in the March 2024 quarter
  26-Jun-24   07:29
Back Top